Exploratory and Safety Study of [F-18]W372
NCT00954369
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Alzheimer's Disease
Interventions
DRUG:
[F-18]W372
Sponsor
Siemens Molecular Imaging